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Abstract Liver mitochondria from rats made hypothyroid by 
administration of 2-mercapto-l-methylimidazole were less sensi-
tive to the uncoupling effect of myristic acid, as measured by the 
increase of resting state respiration, than mitochondria from 
euthyroid animals, whereas subsequent administration to the 
animals of triiodothyronine ('hyperthyroidism') resulted in an 
increased uncoupling action of myristate. 'Hyperthyroidism' also 
resulted in doubling of the carboxyatractyloside-sensitive portion 
of the myristate-stimulated respiration. Parallel to this was a 
twofold increase of the mitochondrial content of the ADP/ATP 
carrier protein and an over threefold increase of its activity. The 
uncoupling effect of phytanic acid was less sensitive to 
carboxyatractyloside and was increased in the hyperthyroid 
state to a smaller extent than in the case of myristate. These 
results provide further support to the thesis [Skulachev, V.P., 
FEBS Lett. 294 (1991) 158-162] that the ADP/ATP carrier is 
involved in the mechanism of the uncoupling effect of long-chain 
fatty acids. 
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1. Introduction 
Administration of thyroid hormones to rats markedly in-
creased oxygen consumption of liver, heart and kidney tissue 
(for review see [1,2]). This stimulation of the cellular respira-
tory capacity is attributed to a thyroid hormone-induced ex-
pression of several nuclear-encoded genes, mainly those of the 
mitochondrial energy coupling system. Thus, increased tissue 
levels of mRNA-encoding proteins, such as cytochrome clc\, 
glycerol 3-phosphate dehydrogenase, ADP/ATP carrier, have 
been found in rat after treatment with T3 [1,2]. These findings 
explain why the control pattern of certain proteins on mito-
chondrial respiration changes with alteration of the thyroid 
hormone status [3]. 
AAC exists in several isoforms in mammals [4,5]. In rat two 
isoforms are expressed in a tissue-specific manner, the muscle-
specific AAC1 form and the ubiquitous AAC2 form [6,7]. In 
rat liver, AAC2 is the main isoform and only its mRNA tissue 
level responds to T3 [7,8]. The mRNA level of AAC2 in-
creased manyfold in rat liver tissue in a time scale of days 
when hypothyroid rats were treated with T3 [7,8]. AAC is a 
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protein of particular interest in the understanding of the mi-
tochondrial energy coupling process because (i) it exerts high 
control on mitochondrial respiration [9,10], (ii) it is involved 
in the mitochondrial permeability transition [11] and (iii) it 
mediates uncoupling of oxidative phosphorylation by non-es-
terified long-chain fatty acids (for review see [12,13]). Partic-
ipation of AAC in FFA-linked uncoupling is clearly seen from 
the observation that ligands of AAC (e.g. carboxyatractylo-
side, atractyloside and acyl-CoA derivatives) depress FFA-
stimulated resting state respiration [14]. In addition, the 
AAC-mediated uncoupling effect of FFA increases with the 
mitochondrial AAC content [15] and, finally, photoaffmity 
immobilisation of FFA on AAC makes mitochondria less 
sensitive to the uncoupling by FFA [16]. It is now widely 
believed that FFAs act as protonophoric uncouplers and 
that AAC mediates the transmembrane movement of the fatty 
acid anion across the inner mitochondrial membrane ([12,13], 
but see also [17]). However, to date it is not known how the 
thyroid hormone status modulates the uncoupling activity of 
FFA. In the present report we show that, in rat liver mito-
chondria, T3 affects strongly the FFA-stimulated (uncoupled) 
respiration and that the T3-induced increase in the AAC pro-
tein content accounts quantitatively for the AAC-sensitive un-
coupled respiration. 
2. Materials and methods 
2.1. Animals and isolation of mitochondria 
The thyroid hormone status of adult female Wistar rats (150-180 g) 
was manipulated either by supply of 2-mercapto-l-methylimidazole 
(methimazole; an inhibitor of thyroid hormone synthesis) in drinking 
water (0.04%) for 15 days (hypothyroidism) or by intraperitoneal in-
jection of T3 (20 μg/100 g body weight per day) administered over 
3 days after methimazole treatment (hyperthyroidism). The thyroid 
hormone status was verified by measuring T3 and T4 levels by 
radio-immunoassay of sera collected at the time of killing the animals. 
Mitochondria from liver and heart were isolated essentially as de-
scribed in [18] and [16], respectively. The prepared mitochondria 
had routinely a respiratory control ratio greater than 8 with glutamate 
plus malate as respiratory substrates. Protein content in mitochondrial 
stock suspensions was determined by a modified biuret method. 
2.2. Measurement of respiration 
The medium was composed of 110 mM mannitol, 60 mM KC1, 60 
mM Tris-HCl, 10 mM potassium phosphate and 0.5 mM Na2EDTA, 
pH 7.4. Oxygen uptake was measured polarographically using a 
Clark-type electrode in a thermostatted chamber maintained at 25°C 
using 3 mg mitochondrial protein suspended in 2.0 ml of the respira-
tion medium. For calculation of respiration rates, oxygen concentra-
tion of 230 nmol CVml was adopted. Partly uncoupled states were 
adjusted by addition of micromolar concentrations of 5 mM ethanolic 
solutions of myristate or phytanate. 
2.3. Content and activity of the ADP/ATP carrier, (ATP+ADP) 
pool size 
The content of AAC protein in samples of mitochondria was esti-
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mated from the high affinity binding of [3H]ATR to the A AC protein 
[18]. Liver mitochondria (1 mg protein) were incubated in 1.0 ml 
medium supplemented with 1 nmol [3H]]ATR (specific activity, 220 
dpm/pmol). Non-specific binding of [3H]ATR to mitochondria was 
determined by incubation of samples with 100 μΜ unlabeled ATR 
prior to the addition of [3H]ATR. The activity of AAC was measured 
at 4°C by the atractyloside-stop method of Pfaff and Klingenberg [19] 
as described in [16]. From the [3H]ADP uptake determined during 
initial 10 s periods translocation activities were calculated and ex-
pressed as nmol ADP/min per mg protein. The size of the exchange-
able pool of adenine nucleotides (ATP+ADP) was estimated from the 
uptake of [3H]ADP after a 5 min incubation period. 
2.4. Materials 
Myristic acid (C14:0), phytanic (3,7,11,15-tetramethylhexadecanoic) 
acid, atractyloside, carboxyatractyloside, 2-mercapto-l-methylimid-
azole, 3,3',5-triiodo-L-thyronine, FCCP, ADP, glutamate, malate 
and succinate were from Sigma (St. Louis, MO, USA). Trypsin (bo-
vine pancreas) was from Serva (Heidelberg/New York). [3H]ADP was 
obtained from NEN-DuPont (Boston, MA, USA). [3H]Atractyloside 
was prepared and purified by Dr. S. Noll (Institute of Bioinorganic 
and Radiopharmaceutical Chemistry, Dresden-Rossendorf, Ger-
many). 
3. Results 
3.1. Thyroid hormone status and mitochondrial respiration 
The consequences of manipulation of the thyroid hormone 
status in rats can be clearly seen from serum levels of T3 and 
T4 and from mitochondrial respiration data (Table 1). In line 
with others (e.g. [3]), the respiration data show that switching 
from hypo- to hyperthyroidism increased twofold state 3 res-
piration and respiration of the fully FCCP-uncoupled state. 
3.2. The effect of triiodothyronine on the activity and the 
content of the ADP I ATP carrier and the (ATP+ADP) 
pool size 
The action of T3 on adenine nucleotide translocation of 
liver mitochondria from euthyroid, hypothyroid and hyper-
thyroid (hypothyroid+T3) rats can be seen from the data 
shown in Fig. 1. Our results provide confirmation of earlier 
observations [20] that mitochondria from hypo- and hyper-
thyroid rats differ markedly in their AAC activity. Thus 
the translocation activity of 'hyperthyroid' mitochondria 
(14.6 ±2.4 nmol/mg protein/min) is almost fourfold that 
found in 'hypothyroid' mitochondria (4.10 ±0.7 nmol/mg pro-
tein/min). 
It has been reported that T3 can stimulate the activity of 
AAC in a way which cannot be attributed to an increased 
content of AAC [20]. Therefore, the observed increase in the 
AAC activity was compared with T3-induced expression of 
AAC in liver. For that, the content of AAC was measured 
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Fig. 1. Effect of the thyroid hormone status on the activity of the 
ADP/ATP carrier. The data represent mean values ± S.D. of five 
separate mitochondrial preparations obtained from each thyroid 
state. 
using [3H]ATR binding to the AAC protein. We found that 
T3 administration to hypothyroid rats increased the mito-
chondrial AAC content twofold, i.e. to the level measured 
in euthyroid animals (see Fig. 2). This increase was due to 
the enrichment of the mitochondrial AAC protein rather than 
to an increased content of mitochondria, since it was similar 
(on a protein basis) in the mitochondrial fraction and in the 
whole homogenate (Fig. 2). With heart mitochondria from 
hypo- and hyperthyroid rats, only a slight increase in the 
AAC protein content was found (from 232 ± 24 to 299 ± 65 
pmol/mg protein, n =5). This was parallelled by only a small 
increase of the myristate-induced respiration (not shown). 
The content of exchangeable adenine nucleotides in liver 
mitochondria was also affected by the thyroid hormone sta-
tus. This pool (ATP+ADP) decreased from 3.8 ±0.6 nmol/mg 
protein (и = 4) in euthyroid animals to 2.6 ±0.2 nmol/mg pro-
tein (n — 5) after methimazole treatment and was restored to 
the original level (4.1 nmol/mg protein ± 0.8 nmol/mg protein, 
n — 4) after administration of T3. 
3.3. Protonophoric activity of fatty acids 
The protonophoric eflfect of long-chain fatty acids on 'hy-
pothyroid' and 'hyperthyroid' mitochondria was studied with 
myristic acid. Fig. 3 shows that myristate stimulates state 4 
respiration in 'hyperthyroid' liver mitochondria much more 
than in 'hypothyroid' mitochondria. Moreover, the CAT-sen-
sitive portion of this respiration was doubled, which fits well 
with the twofold increase of the mitochondrial AAC protein 
content. 
Table 1 
Effect of the thyroid hormone status on the respiration of rat liver mitochondria 
Euthyroid T3 
T4 
Hypothyroid T3 
T4 
Hypothyroid+T3 T3 
T4 
Thyroid status 
Serum level (m 
2.110.6 
189 ±39 
1.410.1 
59±9 
14.111.3 
70±6 
Respiration (nmol CVmin/mg protein) 
State 3 
47 + 6 
(100%) 
3014 
(64%) 
66 + 5 
(140%) 
Uncoupled 
76+10 
(100%) 
52 + 7 
(68%) 
111111 
(146%) 
Rat liver mitochondria (1.5 mg protein/ml) were incubated as described in Section 2 with medium. State 3 respiration was measured with 5 mM 
glutamate plus 5 mM malate as respiratory substrate. Uncoupled respiration was measured with 10 mM succinate plus 1 μΜ rotenone by titration 
of mitochondria with FCCP. The data are means 1 S.D. of seven preparations. 
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Fig. 2. Effect of the thyroid hormone status on the content of the 
ADP/ATP carrier. The data represent mean values ± S.D. obtained 
from each thyroid state. The numbers of separate preparations are 
given in parentheses. 
The effect of T3 on myristate-uncoupled respiration was 
compared with that obtained with phytanic acid. This com-
pound is easily formed in mammals from phytol, which is a 
natural constituent of milk products and vegetable fats. This 
fatty acid accumulates extensively in liver tissue with a defec-
tive peroxisomal ос-oxidation for branched chain fatty acids 
(e.g. the Refsum syndrome) [21]. Fig. 4 shows that phytanic 
acid also exerted an uncoupling effect on liver mitochondria, 
though to a somewhat lower extent than myristic acid (com-
pare Fig. 3). However, the CAT-sensitive portion of phytanic 
acid-stimulated respiration was considerably lower than that 
in the case of myristic acid (18 ± 5% as compared to 39 ±4%). 
Moreover, the magnitude of CAT sensitivity was independent 
of the thyroid hormone status. 
mitochondria and in addition might also result from a differ-
ent cardiolipin content in the inner mitochondrial membrane 
[25,26], as it is known from experiments on AAC reconstitu-
tion into liposomes that cardiolipin is essential for restoration 
of AAC activity [27]. 
Secondly, FFA-stimulated respiration of heart mitochon-
dria only slightly depended on the thyroid hormone status 
of the animals. This was parallelled by small differences in 
the content of AAC in these mitochondria. This, in turn, 
could be explained by the fact that in heart tissue the content 
of the AACl mRNA isoform is 2-5 times higher than that of 
the AAC2 mRNA isoform and that only the AAC2 gene 
responds to thyroid hormones [4,7,8]. 
Finally, uncoupling of liver mitochondria by phytanic acid 
was less stimulated by treatment of hypothyroid rats with T3 
than the uncoupling by myristic acid, which is in line with the 
low sensitivity of the former respiration to CAT. 
The results of the present study also show that the increase 
of myristate-induced respiration is only partly sensitive to 
CAT. This indicates that it is not entirely accounted for by 
an increased expression of the AAC protein. It can therefore 
be concluded that the thyroid hormone status also affects 
other constituents of the inner mitochondrial membrane 
which may be involved in the protonophoric action of fatty 
acids. 
It has been reported [28,29] that hyperthyroidism-associated 
thermogenesis can result from a decrease in the H+/0 ratio 
('slip') or, rather, an increased H + conductance of the inner 
mitochondrial membrane ('leak'). Recently, Skulachev and 
coworkers [30] have reported on seasonal variations in cou-
pling efficiency of rat liver mitochondria and have related this 
phenomenon to the level of thyroid hormones. Moreover, it is 
known that the plasma concentration of FFA is elevated in 
hyperthyroid humans and animals and is diminished in hypo-
thyroid subjects (for review see [31]). Our results indicate that 
4. Discussion 
Uncoupling of oxidative phosphorylation by fatty acids has 
been ascribed to their protonophoric action, comparable to 
that of 'classical' uncouplers (for review see [13]). However, 
because spontaneous transbilayer passage of the fatty acid 
anion is very slow [22], it has been proposed that mitochon-
drial carriers such as the ADP/ATP carrier [12,14], the gluta-
mate carrier [23] and the dicarboxylate carrier [24] facilitate its 
movement from the inner to the outer leaflet of the inner 
mitochondrial membrane, whereas the movement of the pro-
tonated (undissociated) form moves in the opposite direction 
by unmediated flip-flop. The present results provide further 
strong support for this proposed role of AAC [12-17]. This is 
based on the following observations. 
Firstly, T3 administration to hypothyroid rats resulted in a 
twofold increase in the CAT-sensitive myristate-induced mito-
chondrial respiration which was parallelled by a similar en-
richment of the AAC protein. Increased expression of AAC 
by T3 was also reflected by the increase of the adenine nucleo-
tide translocation activity. The discrepancy between the in-
crease in the translocation activity (fourfold) and the enrich-
ment of the AAC protein in mitochondria (twofold) can 
be partly attributed to a difference in the exchangeable 
(ATP+ADP) pool size of 'hypothyroid' and 'hyperthyroid' 
Fig. 3. Effect of the thyroid hormone status on myristate-stimulated 
resting state respiration in the presence and absence of carboxy-
atractyloside. The medium was supplemented with 5 mM glutamate 
plus 5 mM malate as substrates. Respiration was stimulated by the 
addition of 40 nmol myristate/mg protein. At stationary respiration 
carboxyatractyloside was added to a final concentration of 2 μΜ. 
The data are means ± S.D. of 7-9 preparations obtained from each 
thyroid state. 
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Fig. 4. Effect of the thyroid hormone status on phytanate-stimulated 
resting state respiration in the presence and absence of carboxy-
atractyloside. Experimental conditions were as described in the 
legend to Fig. 3. The data are means ± S.D. of 7-9 preparations ob-
tained from each thyroid state. 
elevated tissue concentration of non-esterified fatty acids may 
be responsible for increased thermogenesis in thyroid hor-
mone-responsive tissues. 
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